Exelixis Inc (EXEL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $16.37B
Last updated: Nov 17, 2026 at 4:33 PM ET
Exelixis Inc (EXEL) Stock Chart
Exelixis (EXEL) has a latest price of $68.50 on Nov 17, 2026, 7.0% below its 52-week high of $73.69. Its price rose 64.5% over the past 12 months. The month-end price rose 555.2% over the 10 years through Oct 2026, a compound annual rate of 20.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $69.39 in Oct 2026 and its lowest $10.59 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart EXEL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EXEL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 25.9%, and over 6 months it rose 40.7%. The month-end price rose 237.0% over the 3 years through Oct 2026, a compound annual rate of 49.9%.
| Period | Change |
|---|---|
| 1 month | +9.3% |
| 3 months | +25.9% |
| 6 months | +40.7% |
| 12 months | +64.5% |
| 12 months, with dividends | +64.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +237.0% | +49.9% |
| 5 years | +222.6% | +26.4% |
| 10 years | +555.2% | +20.7% |
Price by Year
Its best calendar year was 2017, when the price rose 103.9%, and its weakest was 2018, when it fell 35.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $69.39 | +58.3% |
| 2025 | $43.83 | +31.6% |
| 2024 | $33.30 | +38.8% |
| 2023 | $23.99 | +49.6% |
| 2022 | $16.04 | -12.3% |
| 2021 | $18.28 | -8.9% |
| 2020 | $20.07 | +13.9% |
| 2019 | $17.62 | -10.4% |
| 2018 | $19.67 | -35.3% |
| 2017 | $30.40 | +103.9% |
Trading Range
The price is 9.3% above its 50-day average of $62.66 and 30.5% above its 200-day average of $52.50.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $68.50 | |
| 52-week high | $73.69 | -7.0% |
| 52-week low | $39.71 | +72.5% |
| 50-day average | $62.66 | +9.3% |
| 200-day average | $52.50 | +30.5% |
Price Risk
Over 3 years, its largest fall from a peak was 25.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.63 |
| Largest fall, 1 year | -12.6% |
| Largest fall, 3 years | -25.3% |
Valuation
Exelixis traded at 14.2x earnings at the end of 2025, against a 5-year median of 18.1x and a 10-year median of 19.2x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About EXEL
What is EXEL's 1-year price change?
Exelixis's price rose 64.5% over the past 12 months. With dividends included, the 12-month total return was 64.5%.
What is EXEL's 5-year price change?
Exelixis's month-end price rose 222.6% over the 5 years through Oct 2026, a compound annual rate of 26.4%. These figures leave out dividends.
What is EXEL's 52-week high and low?
Exelixis's 52-week high is $73.69 and its 52-week low is $39.71. Its latest price of $68.50 on Nov 17, 2026 is 7.0% below the high.
What is EXEL's beta?
Exelixis's 1-year beta against the S&P 500 is 0.63, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 12.6%.
Is the EXEL chart free?
Yes. Advanced Charting for EXEL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
EXEL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors